对于儿科药物开发的药理动力学-药理动力学建模的进展:推断和暴露-反应分析
Sebastiaan C Goulooze1, Peter W Vis1, Elke H J Krekels2
1LAP&P Consultants BV, Leiden, The Netherlands.
Expert review of clinical pharmacology
|December 9, 2023
概括
药理动力学 (PK) - 药理动力学 (PD) 和暴露-反应 (E-R) 建模对于儿科药物开发至关重要. 这些方法提高了研究设计,优化了儿科剂量,并降低了儿童的风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科药物开发 儿科药物开发
- 生物统计学 生物统计学
背景情况:
- 药理动力学 (PK) - 药理动力学 (PD) 和暴露-反应 (E-R) 建模对于有效和安全的儿科药物开发至关重要.
- 这些建模技术整合了现有数据,以告知未来的研究设计和儿科剂量选择,最大限度地降低了与低于最佳剂量相关的风险.
研究的目的:
- 讨论PK,PK-PD和E-R建模在儿科药物开发和剂量选择中的关键作用.
- 要突出这些模型如何分析儿科因素 (如年龄和体重) 对药物效应的影响.
- 解释E-R分析如何支持将药物疗效从成年人群推断到儿科群体.
主要方法:
- 在儿科药物开发的背景下,对PK,PK-PD和E-R建模原理的审查.
- 对儿科人口的数据稀疏建模方法的讨论.
- 对证据的分析支持在儿科年龄组中推断疗效.
主要成果:
- PK-PD和E-R模型允许调查年龄和体重对儿童PK和PD的影响,即使数据有限.
- E-R分析加强了证据来推断儿童年龄组的药物疗效,以及从成年人到儿童的证据.
- 这些建模方法对于优化儿科剂量和加速药物开发至关重要.
结论:
- PK-PD 和 E-R 建模是儿科药物开发和剂量选择的必不可少的工具.
- 在E-R建模,现实世界数据利用和指南实施方面的未来进展将进一步加快儿科药物开发,并完善剂量策略.
相关概念视频
01:20Pharmacokinetic Models: Overview
709
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
709
01:26Pharmacokinetic Models: Comparison and Selection Criterion
74
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
74
01:12Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
71
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
71
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
66
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
66
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
134
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
134